|
Symbol
|
RMACHV | ACKUTQ | ACLATQ | ACRFTQ | RMBDRV | RMBDNV | ADTRTQ | ADZYTQ | RMAV6V |
|---|---|---|---|---|---|---|---|---|---|
| Nom | Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Multi Vonti |
|
Sous-jacent
|
ASML Hldg. N.V. / Novo Nordisk AS (B) / SAP SE | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | ASML Hldg. N.V. / Novo Nordisk AS (B) | ASML Hldg. N.V. / Novo Nordisk AS (B) | Adidas AG / LVMH Moet Hennessy Louis Vuitton / Novo Nordisk AS (B) | Alcon / Novo Nordisk AS (B) / Roche AG | ASML Hldg. N.V. / Novo Nordisk AS (B) / Oracle Corp. |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
17.08.2026 | 17.03.2027 | 17.03.2027 | 14.04.2027 | 13.08.2027 | 13.08.2027 | 20.08.2029 | 08.09.2026 | 11.10.2028 |
| Ratio | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
757,40 | 418,32 | 384,58 | 303,835 | 217,13 | 217,13 | 99,15 | 50,5758 | 188,34 |
| rendement max. p.a. | 172,51% | 26,05% | 18,83% | 13,88% | 8,27% | 6,46% | 9,59% | 14,11% | 16,05% |
| Demande | 55,99 | 85,42 | 89,00 | 96,88 | 102,60 | 102,40 | 98,48 | 99,44 | 83,00 |
| Offre | 57,02 | 86,42 | 90,00 | 97,88 | 104,01 | 103,40 | 99,28 | 100,24 | 83,80 |